1. Home
  2. USNA vs ZVRA Comparison

USNA vs ZVRA Comparison

Compare USNA & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • ZVRA
  • Stock Information
  • Founded
  • USNA 1992
  • ZVRA 2006
  • Country
  • USNA United States
  • ZVRA United States
  • Employees
  • USNA N/A
  • ZVRA N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • USNA Health Care
  • ZVRA Health Care
  • Exchange
  • USNA Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • USNA 565.5M
  • ZVRA 467.6M
  • IPO Year
  • USNA 1996
  • ZVRA 2015
  • Fundamental
  • Price
  • USNA $20.88
  • ZVRA $10.81
  • Analyst Decision
  • USNA Hold
  • ZVRA Strong Buy
  • Analyst Count
  • USNA 1
  • ZVRA 8
  • Target Price
  • USNA $36.00
  • ZVRA $22.57
  • AVG Volume (30 Days)
  • USNA 189.4K
  • ZVRA 2.7M
  • Earning Date
  • USNA 10-21-2025
  • ZVRA 11-11-2025
  • Dividend Yield
  • USNA N/A
  • ZVRA N/A
  • EPS Growth
  • USNA N/A
  • ZVRA N/A
  • EPS
  • USNA 1.80
  • ZVRA N/A
  • Revenue
  • USNA $899,221,000.00
  • ZVRA $62,020,000.00
  • Revenue This Year
  • USNA $13.94
  • ZVRA $336.43
  • Revenue Next Year
  • USNA $7.95
  • ZVRA $54.26
  • P/E Ratio
  • USNA $11.63
  • ZVRA N/A
  • Revenue Growth
  • USNA 2.75
  • ZVRA 161.81
  • 52 Week Low
  • USNA $19.88
  • ZVRA $6.19
  • 52 Week High
  • USNA $41.84
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • USNA 23.23
  • ZVRA 57.36
  • Support Level
  • USNA $19.88
  • ZVRA $10.37
  • Resistance Level
  • USNA $21.46
  • ZVRA $12.03
  • Average True Range (ATR)
  • USNA 0.97
  • ZVRA 0.68
  • MACD
  • USNA -0.55
  • ZVRA 0.15
  • Stochastic Oscillator
  • USNA 12.26
  • ZVRA 61.49

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: